Anatomic and clinical correlates of septal morphology in hypertrophic cardiomyopathy
- PMID: 21044981
- DOI: 10.1093/ejechocard/jeq163
Anatomic and clinical correlates of septal morphology in hypertrophic cardiomyopathy
Abstract
Aim The presence of septal hypertrophy in hypertrophic cardiomyopathy (HCM) is common. To date, there has been no accepted classification of septal morphology in HCM. Furthermore, the possible relationship between septal morphology and clinical features of HCM is undefined.
Methods and results: Seventy-five consecutive adult patients with HCM were enrolled. Septal morphologies were retrospectively categorized into one of four patterns of hypertrophy based on transthoracic echocardiography. Left ventricular diastolic function by Doppler echocardiography and late gadolinium enhancement (LGE) by magnetic resonance imaging were assessed in all patients. Patients were followed for a mean of 45 ± 32 months. Catenoid septum was the most common morphologic subtype (46 of 75, 61%), followed by simple sigmoid (22 of 75, 29%), neutral (4 of 75, 5%), and apical (3 of 75, 4%). Inter-observer reproducibility of septal classifications was high (κ = 0.95). Patients with the catenoid subtype presented at a younger age, had worse diastolic function, and high rates of LGE. The presence of catenoid septal morphology was independently associated with LGE in multivariable logistic regression analysis. Implantable cardioverter-defibrillator implantation for prevention of sudden cardiac death occurred only in patients with this septal morphology.
Conclusion: We propose a simple, reproducible classification system of patterns of septal hypertrophy in HCM. These patterns of hypertrophy are associated with significant differences in clinical, haemodynamic, and myocardial characteristics. Further studies are needed to evaluate the relationship between septal morphology and outcome or response to therapies in HCM.
Similar articles
-
Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.Arch Cardiovasc Dis. 2015 Jun-Jul;108(6-7):356-66. doi: 10.1016/j.acvd.2015.01.010. Epub 2015 Apr 8. Arch Cardiovasc Dis. 2015. PMID: 25863428 Clinical Trial.
-
Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.Int J Cardiovasc Imaging. 2016 Apr;32(4):613-20. doi: 10.1007/s10554-015-0806-8. Epub 2015 Nov 20. Int J Cardiovasc Imaging. 2016. PMID: 26589516
-
Distribution of Hypertrophy and Late Gadolinium Enhancement in Children and Adolescents with Hypertrophic Cardiomyopathy.Congenit Heart Dis. 2015 Nov-Dec;10(6):E258-67. doi: 10.1111/chd.12286. Epub 2015 Jul 20. Congenit Heart Dis. 2015. PMID: 26193909
-
Hypertrophic Cardiomyopathy from A to Z: Genetics, Pathophysiology, Imaging, and Management.Radiographics. 2016 Mar-Apr;36(2):335-54. doi: 10.1148/rg.2016150137. Radiographics. 2016. PMID: 26963450 Review.
-
Do variable age-related secondary factors affect ventricular geometry in hypertrophic cardiomyopathy?Adv Ther. 2002 Nov-Dec;19(6):253-7. doi: 10.1007/BF02853170. Adv Ther. 2002. PMID: 12665045 Review.
Cited by
-
MRI classification of asymmetric septal hypertrophic cardiomyopathy and its relation to the presence of risk factors.Int J Cardiovasc Imaging. 2012 Dec;28(8):2019-25. doi: 10.1007/s10554-012-0034-4. Epub 2012 Mar 4. Int J Cardiovasc Imaging. 2012. PMID: 22392104
-
Hypertrophic cardiomyopathy in the Saudi Arabian population: Clinical and echocardiographic characteristics and outcome analysis.J Saudi Heart Assoc. 2014 Jan;26(1):7-13. doi: 10.1016/j.jsha.2013.08.003. Epub 2013 Aug 20. J Saudi Heart Assoc. 2014. PMID: 24578595 Free PMC article.
-
Heart failure in sub-Saharan Africa.Curr Cardiol Rev. 2013 May;9(2):157-73. doi: 10.2174/1573403x11309020008. Curr Cardiol Rev. 2013. PMID: 23597299 Free PMC article. Review.
-
Takotsubo cardiomyopathy with Basal Hypertrophy and outflow obstruction in a patient with bowel ischemia.Int J Crit Illn Inj Sci. 2018 Jan-Mar;8(1):44-47. doi: 10.4103/IJCIIS.IJCIIS_47_17. Int J Crit Illn Inj Sci. 2018. PMID: 29619340 Free PMC article.
-
Familial Hypertrophic Cardiomyopathy: Diagnosis and Management.Vasc Health Risk Manag. 2023 Apr 6;19:211-221. doi: 10.2147/VHRM.S365001. eCollection 2023. Vasc Health Risk Manag. 2023. PMID: 37050929 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources